Internal Med Medical News about Scleromyxoedema

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Vincristine, Idarubicin, Dexamethasone and Thalidomide in Scleromyxoedema
Acta Dermato-Venereologica, 10/29/09

Laimer M et al. – The article discusses current proposed therapeutic strategies and reports the case of a 64–year– ld male patient with progressive scleromyxoedema associated with IgG– paraproteinaemia in whom monthly administrations of vincristine, idarubicin and dexamethasone in addition to daily oral thalidomide led to clinical and laboratory remission within 12 weeks.

<< Previous
No evidence of increased risk of malignancies in patients with...

Next >>
Detection of Human Herpesvirus 8 in the Skin of Patients with...